Shifting risk profile in radical prostatectomy over 18 years: A bicentric French study of 8,358 patients
Yann Neuzillet(Université de Versailles Saint-Quentin-en-Yvelines), Xavier Cathelineau(Institute Mutualiste Montsouris), Claire Deleuze(Institute Mutualiste Montsouris), Petr Macek(Institute Mutualiste Montsouris), D. Bohin(Université de Versailles Saint-Quentin-en-Yvelines), Camille Lanz(Institute Mutualiste Montsouris), François Rozet(Institute Mutualiste Montsouris), Yanish Soorojebally(Université de Versailles Saint-Quentin-en-Yvelines), Pierre‐Olivier Bosset(Université de Versailles Saint-Quentin-en-Yvelines), Lara Rodriguez Sanchez(Institute Mutualiste Montsouris), Joao Paulo Barbosa De Oliveira(Institute Mutualiste Montsouris), Thierry Lebret(Université de Versailles Saint-Quentin-en-Yvelines), Tarek Ghoneim(Université de Versailles Saint-Quentin-en-Yvelines), Maxime Pattou(Université de Versailles Saint-Quentin-en-Yvelines), Éric Barret(Institute Mutualiste Montsouris), V. Vanalderwerelt(Université de Versailles Saint-Quentin-en-Yvelines)
Cited by 0
Related Papers
FGFR3 Mutation Status and FGFR3 Expression in a Large Bladder Cancer Cohort Treated by Radical Cystectomy: Implications for Anti-FGFR3 Treatment?†
|European Urology|2020|89
Prognostic impact of variant histologies in urothelial bladder cancer treated with radical cystectomy
|British Journal of Urology|2023|64
Urinary biomarkers for bladder cancer diagnosis and NMIBC follow-up: a systematic review
|World Journal of Urology|2023|42
Prognostic markers in invasive bladder cancer: FGFR3 mutation status versus P53 and KI-67 expression: a multi-center, multi-laboratory analysis in 1058 radical cystectomy patients
|Urologic Oncology Seminars and Original Investigations|2021|39